To further identify intracellular mediators underlying the antiproliferative activity of sorafenib, we evaluated the activation of the signal transducer and activator of transcription 3 (STAT3) that mediates transcriptional regulation of genes involved in tumor cell survival in response to growth factors (Fig. 5a). The gene discussed is STAT3; the disease is neoplasm.